세계의 바이오프리저베이션 시장 : 제품, 생물 시료, 용도, 최종 사용자별 예측(2025-2030년)

The Biopreservation Market was valued at USD 2.89 billion in 2023, expected to reach USD 3.64 billion in 2024, and is projected to grow at a CAGR of 26.98%, to USD 15.40 billion by 2030.

Biopreservation is a vital process that involves the use of natural or controlled biological techniques and materials to preserve the integrity and functionality of biological samples. Defined primarily as an approach to prolonging the viability of cells, tissues, and organs, its necessity lies in its application across various sectors including healthcare, pharmaceuticals, and food industries. For instance, in the medical field, biopreservation underpins procedures such as blood and organ preservation, sustaining cellular therapies and regenerative medicine. Processes such as cryopreservation and storage in biobanks further enhance its end-use scope by aiding in the advancement of clinical applications, diagnostics development, and personalized medicine.

The biopreservation market is significantly driven by the rising demand for regenerative medicine, expanded research in medicines owing to the increasing prevalence of chronic diseases, and growth in biobanks. Innovative advances in cryopreservation and advancement in stem cell technology are potential growth opportunities. Strategic partnerships, technological advancements, and increased funding in biotechnology are key tactics to leverage these opportunities. However, limitations include the high cost of preservation equipment, stringent regulatory frameworks, and ethical concerns regarding genetic materials, presenting challenges to industry expansion. Ensuring cost-effectiveness and regulatory compliance alongside innovative practices provides a competitive edge.

Areas for innovation include developing cost-efficient storage solutions, enhancing cryopreservation techniques, and biomaterial research to improve preservation times and efficiency. The market remains highly competitive and dynamic, demanding continuous research and development to ensure high-quality product offerings. Companies entering this domain should focus on strategic collaborations with research agencies and invest in cutting-edge technologies. Tailoring offerings to provide customized solutions to end-users would also enhance market positioning. Overall, while the market is poised for continued growth driven by technology, innovations, and collaborations, addressing ethical concerns and compliance hurdles remains critical in sustaining long-term growth and profitability.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopreservation Market

The Biopreservation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing number of R&D activities by pharmaceutical companies
  • Rising number of well-established biobanks around the world
  • Rapid adoption of biopreservation in the food sector
• Market Restraints
  • High cost of biopreservation equipment
• Market Opportunities
  • Increasing automation in biopreservation, new cryoprotectants, and advanced cooling systems
  • Growing investments in the field of regenerative medicine research
• Market Challenges
  • Availability of alternative technologies for biopreservation

Porter's Five Forces: A Strategic Tool for Navigating the Biopreservation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopreservation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopreservation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopreservation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopreservation Market

A detailed market share analysis in the Biopreservation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopreservation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopreservation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biopreservation Market

A strategic analysis of the Biopreservation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biopreservation Market, highlighting leading vendors and their innovative profiles. These include Audubon Bioscience Co., Azenta, Inc., Bio-Techne Corporation, BioIVT, LLC, BioLife Solutions Inc., Charles River Laboratories International, Inc., Chart Industries, Inc., Eppendorf SE, Exact Sciences Corporation, Helmer Scientific Inc., LANXESS Corporation, Lifeline Scientific Inc., Merck KGaA, MVE Biological Solutions, OPS Diagnostics, LLC, Princeton CryoTech Inc., REPROCELL Inc., Sierra Molecular Corporation, So-Low Environmental Equipment Co., STEMCELL Technologies Inc., Taylor-Wharton, Thermo Fisher Scientific Inc., ThermoGenesis Holdings, Inc., Upkara Inc., and X-Therma Inc..

Market Segmentation & Coverage

This research report categorizes the Biopreservation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Biopreservation Media, Equipment, and Lab Information Management Systems. The Biopreservation Media is further studied across Aldehydes and Cryoprotective Agents. The Equipment is further studied across Consumables, Freezers, Nitrogen Tanks, and Refrigerators.
• Based on Biospecimens, market is studied across Cells, Microorganisms, and Organs.
• Based on Application, market is studied across Bio-Banking, Clinical Trials, Drug Discovery, Regenerative Medicine, and Therapeutics.
• Based on End-User, market is studied across Biobanks, Gene Bank, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing number of R&D activities by pharmaceutical companies
    • 5.1.1.2. Rising number of well-established biobanks around the world
    • 5.1.1.3. Rapid adoption of biopreservation in the food sector
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of biopreservation equipment
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing automation in biopreservation, new cryoprotectants, and advanced cooling systems
    • 5.1.3.2. Growing investments in the field of regenerative medicine research
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of alternative technologies for biopreservation
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Introduction of new biopreservation equipment with improved features and reliability
  • 5.2.2. End-User: Evolving utilization of the biopreservation across the gene banks
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biopreservation Market, by Product

• 6.1. Introduction
• 6.2. Biopreservation Media
  • 6.2.1. Aldehydes
  • 6.2.2. Cryoprotective Agents
• 6.3. Equipment
  • 6.3.1. Consumables
  • 6.3.2. Freezers
  • 6.3.3. Nitrogen Tanks
  • 6.3.4. Refrigerators
• 6.4. Lab Information Management Systems

7. Biopreservation Market, by Biospecimens

• 7.1. Introduction
• 7.2. Cells
• 7.3. Microorganisms
• 7.4. Organs

8. Biopreservation Market, by Application

• 8.1. Introduction
• 8.2. Bio-Banking
• 8.3. Clinical Trials
• 8.4. Drug Discovery
• 8.5. Regenerative Medicine
• 8.6. Therapeutics

9. Biopreservation Market, by End-User

• 9.1. Introduction
• 9.2. Biobanks
• 9.3. Gene Bank
• 9.4. Hospitals

10. Americas Biopreservation Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Biopreservation Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Biopreservation Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. X-Therma Secures USD 22.4 Million in Series B Funding to Advance Biopreservation Solutions
  • 13.3.2. BioLife Solutions Expands Cryopreservation Line with High-Capacity IntelliRate i67C Tabletop Freezer for Cell Therapies
  • 13.3.3. Upkara Secures USD 9 Million Series A for Revolutionary Biopreservation Technology Enabling Ambient Temperature Storage and Transport
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Audubon Bioscience Co.
• 2. Azenta, Inc.
• 3. Bio-Techne Corporation
• 4. BioIVT, LLC
• 5. BioLife Solutions Inc.
• 6. Charles River Laboratories International, Inc.
• 7. Chart Industries, Inc.
• 8. Eppendorf SE
• 9. Exact Sciences Corporation
• 10. Helmer Scientific Inc.
• 11. LANXESS Corporation
• 12. Lifeline Scientific Inc.
• 13. Merck KGaA
• 14. MVE Biological Solutions
• 15. OPS Diagnostics, LLC
• 16. Princeton CryoTech Inc.
• 17. REPROCELL Inc.
• 18. Sierra Molecular Corporation
• 19. So-Low Environmental Equipment Co.
• 20. STEMCELL Technologies Inc.
• 21. Taylor-Wharton
• 22. Thermo Fisher Scientific Inc.
• 23. ThermoGenesis Holdings, Inc.
• 24. Upkara Inc.
• 25. X-Therma Inc.